Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1990 1
1992 1
1994 1
2000 1
2003 1
2005 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Intravenous immune globulin therapy for early-onset sepsis in premature neonates.
Weisman LE, Stoll BJ, Kueser TJ, Rubio TT, Frank CG, Heiman HS, Subramanian KN, Hankins CT, Anthony BF, Cruess DF, et al. Weisman LE, et al. Among authors: kueser tj. J Pediatr. 1992 Sep;121(3):434-43. doi: 10.1016/s0022-3476(05)81802-5. J Pediatr. 1992. PMID: 1517923 Free article. Clinical Trial.
Multicenter study to determine antibody concentrations and assess the safety of administration of INH-A21, a donor-selected human Staphylococcal immune globulin, in low-birth-weight infants.
Capparelli EV, Bloom BT, Kueser TJ, Oelberg DG, Bifano EM, White RD, Schelonka RL, Pearlman SA, Patti J, Hetherington SV. Capparelli EV, et al. Among authors: kueser tj. Antimicrob Agents Chemother. 2005 Oct;49(10):4121-7. doi: 10.1128/AAC.49.10.4121-4127.2005. Antimicrob Agents Chemother. 2005. PMID: 16189088 Free PMC article.
Multicenter study to assess safety and efficacy of INH-A21, a donor-selected human staphylococcal immunoglobulin, for prevention of nosocomial infections in very low birth weight infants.
Bloom B, Schelonka R, Kueser T, Walker W, Jung E, Kaufman D, Kesler K, Roberson D, Patti J, Hetherington S; INH-A21 Phase II Study Team. Bloom B, et al. Among authors: kueser t. Pediatr Infect Dis J. 2005 Oct;24(10):858-66. doi: 10.1097/01.inf.0000180504.66437.1f. Pediatr Infect Dis J. 2005. PMID: 16220082 Clinical Trial.